ACIU AC Immune: Accounting Value per Share

AC Immune (ACIU) - corporate logo

Investment inflows into AC Immune (ACIU) are driven by alliances with global pharmaceutical leaders to develop Alzheimer's treatments, while the market value of 0.48 already prices in trial risks. Massive expenditures and patent complexities make this sector accessible only to financially stable players. The price chart, which assists in the asset's baseline valuation, reflects the dynamics of a company developing neuro-drugs with a reliable cold-chain transportation system for components.

AC Immune S.A. (ACIU) Equity per Share: for the period 07/04/2022 - 10/27/2026

acimmune.com - analytical breakdowns and key metrics (ACIU)

- price and consensus price forecast:
Stock Price AC Immune Corp|ACIU - Analyst Median Target
- market capitalization data:
Market Valuation AC Immune SA|ACIU - Enterprise Value
- book capitalization data:
Net Assets per Single Share AC Immune|ACIU - Accounting Capitalization|Market Capitalization to Book Value Ratio acimmune.com|ACIU - Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio AC Immune|ACIU - Long-Term Debt to Capital|Short-Term Debt to Equity AC Immune SA|ACIU - Aggregate Debt Obligations|Debt to Book Capitalization Ratio AC Immune SA
Fundamental company valuation:AC Immune Corp, ACIU
Manufactured products of AC Immune SA

Investors use this metric to assess the intrinsic value of the business, determining the residual equity per share after all liabilities are settled. The current value of 0.48 reflects the actual resource reserve of AC Immune, which, in the absence of revenue and amid high clinical trial risks for Alzheimer's drugs, serves as the sole barrier against devaluation, as clearly demonstrated by the fair book value per share.

Competitors of AC Immune (ACIU)

Book Value per Share BIIB (Biogen Corp)|Neurocrine Corp (NBIX) - Net Assets per Share|RGC: Accounting Value per Share|AXSM (axsome.com) - Book Value per Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|Trevi Corp (TRVI) - Net Asset Value per Share|PRAX (Praxis Precision Medicines) - Book Value per Share|Book Value per Share anavex.com|Book Value per Share CBLL (CeriBell)|Accounting Value per Share Prothena Corporation PRTA|Accounting Value per Share Alector|Accounting Value of a Share Annexon Biosciences Inc. ANNX|Book Value per Share OMER (Omeros Corp.)|NGNE: Net Assets per Share|VYGR (Voyager Therapeutics, Inc.) - Net Assets per Single Share|NMRA (Neumora) - Accounting Value per Share|Net Assets per Single Share SCLX|Accounting Value per Share Tevogen Bio Inc. (TVGN)|Accounting Value per Share ACOG|Book Value per Share CGTX (Cognition Therapeutics Inc.)|IKT - Net Assets per Single Share|Equity per Share Cassava Sciences Inc SAVA|ASRT (Assertio Therapeutics) - Book Value per Share|COYA - Net Asset Value per Share|VTGN: Book Value per Share|Ovid Therapeutics (OVID) - Book Value per Share|Book Value per Share ABOS|Accounting Value per Share CervoMed, Inc.|ATHE (Alterity Therapeutics) - Book Value per Share|Net Assets per Share clene.com CLNN|Accounting Value per Share PEPG (PepGen)|Jupiter Neurosciences, Inc. - Book Value per Share|Relmada Therapeutics, Inc. (RLMD) - Net Assets per Single Share|ANVS - Equity per Share|Book Value per Share GRCE|Net Asset Value per Share Firefly Neuro|KLTO (ANEW Medical) - Accounting Value per Share|Book Value per Share NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Net Assets per Single Share|Accounting Value of a Share MTVA (metaviatx.com)|NRXS: Net Assets per Single Share|Net Asset Value per Share Helius Medical Technologies, Inc. HSDT|Passage Bio Corp - Book Value per Share|NEUP - Book Value per Share|NERV (Minerva Neurosciences, Inc.) - Book Value per Share|Accounting Value per Share Athira Pharma Inc|ADXN - Accounting Value per Share|Accounting Value of a Share Alzamend|CYCN (Cyclerion Therapeutics) - Book Value per Share|Net Assets per Share PTIX (protagenic.com)|Pasithea Therapeutics Corp. - Net Assets per Single Share|Cortigent Inc - Accounting Value per Share|ATXI: Net Assets per Single Share|BrainStorm Cell Therapeutics Inc. (BCLI) - Accounting Value per Share|CARA: Accounting Value per Share|CHRO (chromocell.com) - Book Value per Share|Net Assets per Single Share Eliem Therapeutics, Inc. (ELYM)|Equity per Share Intra-Cellular|Longboard Pharma - Book Value per Share|Net Asset Value per Share Marinus Pharma (MRNS)|Book Value per Share NKGN (NKGen Biotech, Inc.)|Book Value per Share neurobopharma.com NRBO|SAGE: Book Value per Share|SNPX - Accounting Value per Share|Trevena, Inc - Book Value per Share|Net Assets per Share Vigil Neuroscience, Inc.|WENA (Anew Medical) - Accounting Value per Share|Book Value per Share CERE